Federica Tomao

8.5k total citations
243 papers, 4.9k citations indexed

About

Federica Tomao is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Federica Tomao has authored 243 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Oncology, 73 papers in Reproductive Medicine and 56 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Federica Tomao's work include Ovarian cancer diagnosis and treatment (59 papers), Endometrial and Cervical Cancer Treatments (33 papers) and Cancer Treatment and Pharmacology (25 papers). Federica Tomao is often cited by papers focused on Ovarian cancer diagnosis and treatment (59 papers), Endometrial and Cervical Cancer Treatments (33 papers) and Cancer Treatment and Pharmacology (25 papers). Federica Tomao collaborates with scholars based in Italy, Malaysia and United States. Federica Tomao's co-authors include Pierluigi Benedetti Panici, Angelo Zullo, Innocenza Palaia, Anselmo Papa, Luigi Rossi, Patrizia Vici, Ludovico Muzii, Cesare Hassan, Violante Di Donato and Davide Caruso and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Federica Tomao

234 papers receiving 4.8k citations

Peers

Countries citing papers authored by Federica Tomao

Since Specialization

Citations

This map shows the geographic impact of Federica Tomao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Tomao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Tomao more than expected).

Fields of papers citing papers by Federica Tomao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Tomao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Tomao. The network helps show where Federica Tomao may publish in the future.

Co-authorship network of co-authors of Federica Tomao

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Tomao. A scholar is included among the top collaborators of Federica Tomao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Tomao. Federica Tomao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey 2024 ·Journal of Gynecologic Oncology ·Innocenza Palaia, Giuseppe Caruso, Violante Di Donato, (unknown), Antonella Savarese, Giorgia Perniola, (unknown), Andrea Giannini, (unknown), Giorgio Bogani, Federica Tomao, Diana Giannarelli, (unknown), (unknown), Ludovico Muzii, Sandro Pignata, (unknown)	4
2	Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions 2023 ·International Journal of Gynecological Cancer ·Giuseppe Caruso, Federica Tomao, Gabriella Parma, (unknown), Francesco Multinu, Innocenza Palaia, Giovanni Aletti, Nicoletta Colombo	25
3	Imaging of Peritoneal Carcinomatosis in Advanced Ovarian Cancer: CT, MRI, Radiomic Features and Resectability Criteria 2023 ·Cancers ·(unknown), (unknown), Federica Tomao, (unknown), (unknown), Innocenza Palaia, (unknown), (unknown), (unknown), Francesca Maccioni, Paolo Ricci, Carlo Catalano, Stefania Rizzo, Lucia Manganaro	11
4	The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study 2022 ·SHILAP Revista de lepidopterología ·Michela Roberto, (unknown), Emanuela Pilozzi, (unknown), Genoveffa Balducci, Paolo Mercantini, Andrea Laghi, (unknown), (unknown), Daniele Marinelli, Federica Tomao, Paolo Marchetti, (unknown)	4
5	Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients 2022 ·Gynecologic and Obstetric Investigation ·Violante Di Donato, Ottavia D’Oria, Andrea Giannini, Giorgio Bogani, Margherita Fischetti, Giusi Santangelo, Federica Tomao, Innocenza Palaia, Giorgia Perniola, Ludovico Muzii, Pierluigi Benedetti Panici	41
6	In Vivo Imaging-Based Techniques for Early Diagnosis of Oral Potentially Malignant Disorders—Systematic Review and Meta-Analysis 2021 ·International Journal of Environmental Research and Public Health ·Marta Mazur, Artnora Ndokaj, (unknown), Michela Roberto, (unknown), Maciej Jedliński, Federica Tomao, Iole Vozza, Grzegorz Trybek, Livia Ottolenghi, Fabrizio Guerra	15
7	Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches 2020 ·SHILAP Revista de lepidopterología ·Innocenza Palaia, Federica Tomao, (unknown), Lucia Musacchio, (unknown)	3
8	Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients? 2020 ·Journal of Clinical Medicine ·Lucia Musacchio, Serena Maria Boccia, Giuseppe Caruso, Giusi Santangelo, Margherita Fischetti, Federica Tomao, Giorgia Perniola, Innocenza Palaia, Ludovico Muzii, Sandro Pignata, Pierluigi Benedetti Panici, Violante Di Donato	44
9	Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL) 2020 ·Cancers ·Chiara Napoletano, (unknown), (unknown), Zilu Ye, Hassan Rahimi, Ilaria Grazia Zizzari, Marco Dionisi, Bruna Cerbelli, Federica Tomao, Deborah French, Giulia d’Amati, Pierluigi Benedetti Panici, Sergey Y. Vakhrushev, Henrik Clausen, Marianna Nuti, Aurelia Rughetti	14
10	Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review 2020 ·Oncology ·Violante Di Donato, Innocenza Palaia, (unknown), Lucia Musacchio, Giusi Santangelo, Federica Mauro, Anna Di Pinto, Angela Musella, Margherita Fischetti, Federica Tomao, Giorgia Perniola, Pierluigi Benedetti Panici	14
11	Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 2020 ·Clinical Breast Cancer ·Fabio Marazzi, Roberto Barone, Valeria Masiello, Valentina Magri, Antonino Mulè, Angela Santoro, (unknown), Luca Boldrini, Gianluca Franceschini, (unknown), Giuseppe Naso, Federica Tomao, Maria Antonietta Gambacorta, Giovanna Mantini, Riccardo Masetti, D. Smaniotto, Vincenzo Valentini	3
12	Recurrent mantle cell lymphoma in the uterine cervix: a case report 2020 ·Journal of Medical Case Reports ·Giusi Santangelo, Innocenza Palaia, Giorgia Perniola, Anna Di Pinto, Angela Musella, Federica Tomao, Margherita Fischetti, María Carolina Cabrera Schulmeyer, Maria Grazia Piccioni, Violante Di Donato, Pierluigi Benedetti Panici	0
13	Bevacizumab and others. Activity and safety of anti-VEGF agents in ovarian cancer 2019 ·Recenti Progressi in Medicina ·Monica Verrico, Luigi Rossi, Vincenzo Bianco, Federica Tomao	0
14	The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients 2018 ·Journal of Gynecologic Oncology ·Violante Di Donato, (unknown), (unknown), Federica Tomao, Angela Musella, Giorgia Perniola, Pierluigi Benedetti Panici	17
15	Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer 2018 ·Cancer Treatment Reviews ·Angela Musella, Erlisa Bardhi, Cláudia Marchetti, Laura Vertechy, Giusi Santangelo, María Carolina Cabrera Schulmeyer, Federica Tomao, (unknown), R D'Amelio, Marco Monti, Innocenza Palaia, Ludovico Muzii, Pierluigi Benedetti Panici	50
16	Innovazioni terapeutiche nel trattamento del tumore ovarico. Analisi del percorso per lo sviluppo terapeutico: dal platino all’immunoterapia 2017 ·Recenti Progressi in Medicina ·(unknown), Pierangela Sepe, Anselmo Papa, Federica Tomao	1
17	Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum‐free interval: Myth or reality? 2017 ·Cancer ·Federica Tomao, Maurizio D’Incalci, Elena Biagioli, Fedro A. Peccatori, Nicoletta Colombo	47
18	Inhibition of Tumor Growth and Angiogenesis by SP-2, an Anti–Lectin, Galactoside-Binding Soluble 3 Binding Protein (LGALS3BP) Antibody 2014 ·Molecular Cancer Therapeutics ·Sara Traini, Enza Piccolo, Nicola Tinari, Cosmo Rossi, Rossana La Sorda, Francesca Spinella, Anna Bagnato, Rossano Lattanzio, Maurizia DʼEgidio, (unknown), Federica Tomao, Antonino Grassadonia, Mauro Piantelli, Clara Natoli, Stefano Iacobelli	28
19	Trastuzumab in metastatic breast cancer. 2006 ·PubMed ·Federica Tomao, Evelina Miele, Gian Paolo Spinelli, Michelangelo Russillo, (unknown)	1
20	Ovarian cancer and dietary habits. 1992 ·PubMed ·Federica Tomao, F. Taggi, (unknown), Claudio Villani	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact